Author: OurCrowd

[Medisafe in Medisafe] Medisafe announces launch of GOMEKLI™ Digital Companion to support patients with NF1-PN Taking GOMEKLI

BOSTON, MA / May 13, 2025 / Medisafe, the leading digital health platform for medication engagement, today announced a collaboration with SpringWorks Therapeutics to launch the GOMEKLI™ (mirdametinib) Digital Companion by Medisafe—an innovative, behaviorally driven platform designed to support GOMEKLI patients living with neurofibromatosis type 1 (NF1) and symptomatic, inoperable plexiform neurofibromas (NF1-PN). Read...

Read More

[Alpha Tau in Globe Newswire] Alpha Tau announces appointment of Nadav Kidron to its Board of Directors

JERUSALEM, May 12, 2025 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, announced today that Mr. Nadav Kidron, the President, CEO, and Chairman of the Board of Oramed Pharmaceuticals Inc., (“Oramed”), has been appointed to the Company’s Board of Directors (“Board”). The appointment follows the recent closing of a strategic investment between the Company and an affiliate of Oramed. Read...

Read More